The purpose of this study was to use serial imaging to gain insight into the sequence of
pathologic events in Alzheimer's disease, and the clinical features associated with this sequence. …

The rationale was to develop recommendations on the use of 18 F-FDG PET in breast,
colorectal, esophageal, head and neck, lung, pancreatic, and thyroid cancer; lymphoma, …

To date, most diagnostic imaging comparisons between amyloid labelling ligands and other
imaging modalities have been between the use of amyloid labelling ligand 11 C Pittsburgh …

Background/Aims: 18 F-fluorodeoxyglucose uptake allows estimation of glucose metabolism
by tumor cells using positron emission tomography (PET). We evaluated the role of PET …

PURPOSE Solitary pulmonary nodules (SPNs) are commonly identified by chest radiographs
and computed tomography (CT). Biopsies are often performed to evaluate the nodules …

Introduction Our goal was to develop cut points for amyloid positron emission tomography (PET),
tau PET, flouro-deoxyglucose (FDG) PET, and MRI cortical thickness. Methods We …

The authors assessed the role of positron emission tomography (PET) with fluorine-18
fluorodeoxyglucose (FDG) in differentiation of benign from malignant focal pulmonary …

Plasma phosphorylated tau 181 (P-tau181) and 217 (P-tau217) are indicators of both amyloid
and tau pathology in clinical settings, but their performance in heterogeneous community-…

Background It is essential to determine the specificity of AV-1451 PET for tau in brain
imaging by using pathological comparisons. We performed autoradiography in autopsy-confirmed …

Introduction We examined and compared plasma phospho-tau181 (pTau181) and total tau: (1)
across the Alzheimer's disease (AD) clinical spectrum; (2) in relation to brain amyloid β (…